Skip to main content
Satellos Bioscience Inc. (TSX:MSCL)
Canada flag Canada · Delayed Price · Currency is CAD
10.41
+0.57 (5.79%)
Apr 28, 2026, 3:59 PM EST

Satellos Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-24.87-20.63-12.03-8.37-12.25
Upgrade
Depreciation & Amortization
00.020.010.250.13
Upgrade
Asset Writedown & Restructuring Costs
-2.91-2.13-
Upgrade
Loss (Gain) From Sale of Investments
----0.03-
Upgrade
Stock-Based Compensation
3.241.641.641.060.77
Upgrade
Other Operating Activities
-0.48-1.431.330.057.76
Upgrade
Change in Accounts Receivable
----0.03
Upgrade
Change in Accounts Payable
0.51.010.60.54-0.31
Upgrade
Change in Other Net Operating Assets
-1.98-1.77-0.320.2-0.11
Upgrade
Operating Cash Flow
-23.6-18.25-8.77-4.17-3.98
Upgrade
Capital Expenditures
-0.01-0-0.01-0-0.01
Upgrade
Cash Acquisitions
----1.38
Upgrade
Investment in Securities
-9.414.66-13.27--
Upgrade
Investing Cash Flow
-9.424.66-13.28-01.37
Upgrade
Short-Term Debt Issued
--1.81--
Upgrade
Long-Term Debt Issued
----0.15
Upgrade
Total Debt Issued
--1.81-0.15
Upgrade
Short-Term Debt Repaid
---1.99--
Upgrade
Total Debt Repaid
---1.99--
Upgrade
Net Debt Issued (Repaid)
---0.18-0.15
Upgrade
Issuance of Common Stock
2.2430.6626.621.475.74
Upgrade
Other Financing Activities
-6.9211.740.58-
Upgrade
Financing Cash Flow
2.2437.5738.192.055.89
Upgrade
Foreign Exchange Rate Adjustments
0.5-0.59-0.88-0.06-0
Upgrade
Net Cash Flow
-30.2723.3915.25-2.183.28
Upgrade
Free Cash Flow
-23.6-18.26-8.79-4.17-3.98
Upgrade
Free Cash Flow Per Share
-1.62-1.91-1.22-1.40-1.99
Upgrade
Levered Free Cash Flow
-14.76-11.72-5.49-1.85-0.13
Upgrade
Unlevered Free Cash Flow
-14.76-11.72-5.41-1.85-0.1
Upgrade
Change in Working Capital
-1.48-0.750.280.73-0.38
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.